Enanta Pharmaceuticals Inc (ENTA) stock
ENTANasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-K on Nov 18, 2026Score 2/302% above fair value
$8.23−0.46 (-5.29%)
Close on Nov 18, 2026Market cap $239.70MP/E –Yield –
Enanta Pharmaceuticals total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
No total debt figures for Enanta Pharmaceuticals
Enanta Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?